The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
Self-citationBortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Hoster, E., Dreyling, M., Klapper, W., Gisselbrecht, C., van Hoof, A., Kluin-Nelemans, H. C., Pfreundschuh, M., Reiser, M., Metzner, B., Einsele, H., et al. (2008) · Blood · doi:10.1182/blood-2007-06-095331 · Cited by 984
Orlowski, R. Z., Stinchcombe, T. E., Mitchell, B. S., Shea, T. C., Baldwin, A. S., Stahl, S., Adams, J., Esseltine, D.-L., Elliott, P. J., Pien, C. S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.133 · Cited by 760
Self-citationFisher, R. I., Bernstein, S. H., Kahl, B. S., Djulbegovic, B., Robertson, M. J., de Vos, S., Epner, E., Krishnan, A., Leonard, J. P., Lonial, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9665 · Cited by 704
Self-citationRichardson, P. G., Briemberg, H., Jagannath, S., Wen, P. Y., Barlogie, B., Berenson, J., Singhal, S., Siegel, D. S., Irwin, D., Schuster, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7779 · Cited by 649
O'Connor, O. A., Wright, J., Moskowitz, C., Muzzy, J., MacGregor-Cortelli, B., Stubblefield, M., Straus, D., Portlock, C., Hamlin, P., Choi, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.050 · Cited by 577
Self-citationGoy, A., Younes, A., McLaughlin, P., Pro, B., Romaguera, J. E., Hagemeister, F., Fayad, L., Dang, N. H., Samaniego, F., Wang, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.108 · Cited by 526
Self-citationStrauss, S. J., Maharaj, L., Hoare, S., Johnson, P. W., Radford, J. A., Vinnecombe, S., Millard, L., Rohatiner, A., Boral, A., Trehu, E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6789 · Cited by 170
Self-citationBelch, A. R., Kouroukis, C. T., Crump, M., Sehn, L. H., Gascoyne, R. D., Klasa, R. J., Powers, J., Wright, J. R., & Eisenhauer, E. A. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl316 · Cited by 162
Current Treatment Approaches for Mantle-Cell Lymphoma
Witzig, T. E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.55.017 · Cited by 153
Update on the molecular biology of mantle cell lymphoma
Bertoni, F., Rinaldi, A., Zucca, E., & Cavalli, F. (2006) · Hematological Oncology · doi:10.1002/hon.767 · Cited by 103
Fayad, L., Thomas, D. A., & Romaguera, J. E. (2007) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2007.s.034 · Cited by 60
Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.
Miguel, J. F. S., Richardson, P. G. G., Sonneveld, P., Schuster, M., Irwin, D. H., Stadtmauer, E., Facon, T. T. F., Harousseau, J., Ben‐Yehuda, D., Lonial, S., et al. (2005) · Blood · doi:10.1182/blood.v106.11.366.366 · Cited by 47
Self-citationBiology and therapy of mantle cell lymphoma
Williams, M. E., & Densmore, J. J. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000174039.69656.2b · Cited by 44
Potential biomarkers of bortezomib activity in mantle cell lymphoma from the phase 2 PINNACLE trial
Goy, A. H., Bernstein, S. H., McDonald, A. A., Pickard, M. D., Shi, H., Fleming, M. D., Bryant, B. M., Trepicchio, W. L., Fisher, R. I., Boral, A. L., et al. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.483302 · Cited by 34
Self-citationTreatment of Myeloma — Are We Making Progress?
Durie, B. G. M. (2008) · New England Journal of Medicine · doi:10.1056/nejme0805176 · Cited by 17
Cited by
Inflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184
Advani, R. H., Buggy, J. J., Sharman, J. P., Smith, S. M., Boyd, T. E., Grant, B., Kolibaba, K. S., Furman, R. R., Rodriguez, S., Chang, B. Y., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7906 · Cited by 1,128
Dreyling, M., Campo, E., Hermine, O., Jerkeman, M., Le Gouill, S., Rule, S., Shpilberg, O., Walewski, J., & Ladetto, M. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx223 · Cited by 741
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
Pérez-Galán, P., Dreyling, M., & Wiestner, A. (2011) · Blood · doi:10.1182/blood-2010-04-189977 · Cited by 394
Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
Robak, T., Huang, H., Jin, J., Zhu, J., Liu, T., Samoilova, O., Pylypenko, H., Verhoef, G., Siritanaratkul, N., Osmanov, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412096 · Cited by 386
Metadata
- Authors
- Goy, A., Bernstein, S. H., Kahl, B. S., Djulbegovic, B., Robertson, M. J., de Vos, S., Epner, E., Krishnan, A., Leonard, J. P., Lonial, S., Nasta, S., O'Connor, O. A., Shi, H., Boral, A. L., & Fisher, R. I.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 20
- Issue
- 3
- Pages
- 520-525
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2106904404
- Cited by
- 336
- References
- 17
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.